Article
Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 Feb 2005
Novak Richard M, Chen Li, MacArthur Rodger D, Baxter John D, Huppler Hullsiek Kathy, Peng Grace, Xiang Ying, Henely Christopher, Schmetter Barry, Uy Jonathan, van den Berg-Wolf Mary, Kozal Michael
Abstract excerpt
BACKGROUND: The prevalence of drug resistance among persons with newly acquired human immunodeficiency virus (HIV) infection is well documented. However, it is unclear to what extent these mutations persist in chronically infected, treatment-naive patients. METHODS: Prevalence of and factors associated with genotypic drug resistance were analyzed retrospectively in a subset of 491 chronically HIV-infected,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
